MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
about
Infectious MononucleosisDetecting Antigen-Specific T Cell Responses: From Bulk Populations to Single CellsPosttransplant lymphoproliferative disease after pediatric solid organ transplantationThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseInfectious mononucleosis.MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.Efficient Culture of Human Naive and Memory B Cells for Use as APCs.Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.T memory stem cells in health and disease.Human immunity against EBV-lessons from the clinic.Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases.Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.EBV-Associated Cancer and Autoimmunity: Searching for Therapies.CD4 T cells specific for a latency-associated γ-herpesvirus epitope are polyfunctional and cytotoxic.Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects.Peptide matching between Epstein-Barr virus and human proteins.Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection.Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot.
P2860
Q26783692-78BF35E2-B7BE-476F-A139-877B5E02932AQ26798132-1630DDE2-BCD1-4FAE-893F-D207923058ABQ26866013-BC2AD242-73A8-4FE8-8A0E-063C3EB15123Q26998401-7B43B426-15F3-436E-8DFA-A2C37B336597Q28084340-113E83A0-B423-4226-84F1-D037C4BCEFE6Q34984511-6AA26C1A-94A9-4B3A-971E-925783CE4166Q35223805-B218DE8A-013B-4F9B-BA5C-027BE0126550Q35915780-2E39BF1A-9709-47D5-A72D-14AD621E81F7Q36126324-0AB57A0F-706E-44DF-B6AE-040F3EDDEA88Q36736361-AFB57DCC-FCE9-4CAE-A282-56D224087DFCQ36764365-BD9C5147-E593-438F-AD6B-DF9CD3A8EF02Q36991772-BC375990-54E6-4B2D-BE1F-08D18620E839Q37336847-CB977F8A-C800-44F2-8127-D23F5ED068F0Q37667998-552C6EDD-FF8F-4646-A829-19ADC164F4B6Q37745980-6DC948B8-D971-4B39-AB02-493BB71ED687Q38732881-6AC98C2D-7C78-44CA-AB9B-F56B69FFE866Q38820674-62B47D62-2932-4C87-87BC-338BCAAA706BQ39049093-462B8D1B-800E-47E1-A66C-4D1464A26D34Q39070577-3DB3F634-2917-4BB8-945D-9DA185DC2587Q39097082-6DBFA852-B695-4925-BD3D-412DF11D28EFQ39170011-D79E8D5F-3359-4470-97C7-B7C55235E103Q39219487-D6C2AD9F-954B-4C87-8C75-EC57B6E8E04EQ40073024-45EF6029-06BB-4728-97A7-AB118956C5E5Q40774020-2B33332E-650F-40A3-BE49-A1E87373A8A5Q41012612-73B705CB-57C2-4D15-8391-A00389F25453Q41672415-11FFBFA3-BC2B-4FA1-869E-32BF93300CE6Q41991727-FA0877D1-4042-44EE-BF70-A6DF770438D4Q42282416-1C3560A5-CB3C-4CEC-AE77-CF4F63FC2889Q48343602-26694CEF-DFF3-41E0-B6BA-89250A873A4FQ54236409-E938958B-9800-440D-BF0A-C49026850467Q55057118-8DA4972A-C7B5-4BDA-A689-7A90B6F0249BQ55212175-3AB9430D-0B34-4150-90D5-976AB35C82B7
P2860
MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
MHC II tetramers visualize hum ...... uclear antigen EBNA1 response.
@en
type
label
MHC II tetramers visualize hum ...... uclear antigen EBNA1 response.
@en
prefLabel
MHC II tetramers visualize hum ...... uclear antigen EBNA1 response.
@en
P2093
P2860
P50
P356
P1476
MHC II tetramers visualize hum ...... nuclear antigen EBNA1 response
@en
P2093
Alan B Rickinson
Alison M Leese
Gordon B Ryan
Heather M Long
Laura T Morton
Shereen Sabbah
William Kwok
P2860
P304
P356
10.1084/JEM.20121437
P407
P577
2013-04-08T00:00:00Z